ES536286A0 - Un procedimiento para la preparacion de compuestos de 1,4,4-triazolona. - Google Patents

Un procedimiento para la preparacion de compuestos de 1,4,4-triazolona.

Info

Publication number
ES536286A0
ES536286A0 ES536286A ES536286A ES536286A0 ES 536286 A0 ES536286 A0 ES 536286A0 ES 536286 A ES536286 A ES 536286A ES 536286 A ES536286 A ES 536286A ES 536286 A0 ES536286 A0 ES 536286A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
triazolone compounds
triazolone
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES536286A
Other languages
English (en)
Other versions
ES8601966A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24145128&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES536286(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ES8601966A1 publication Critical patent/ES8601966A1/es
Publication of ES536286A0 publication Critical patent/ES536286A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ES536286A 1983-09-30 1984-09-27 Un procedimiento para la preparacion de compuestos de 1,4,4-triazolona. Granted ES536286A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/538,027 US4613600A (en) 1983-09-30 1983-09-30 Antidepressant 1,2,4-triazolone compounds

Publications (2)

Publication Number Publication Date
ES8601966A1 ES8601966A1 (es) 1985-11-16
ES536286A0 true ES536286A0 (es) 1985-11-16

Family

ID=24145128

Family Applications (1)

Application Number Title Priority Date Filing Date
ES536286A Granted ES536286A0 (es) 1983-09-30 1984-09-27 Un procedimiento para la preparacion de compuestos de 1,4,4-triazolona.

Country Status (25)

Country Link
US (1) US4613600A (es)
JP (1) JPS60100560A (es)
KR (1) KR880002624B1 (es)
AT (1) AT387963B (es)
AU (1) AU561460B2 (es)
BE (1) BE900714A (es)
CA (1) CA1237723A (es)
CH (1) CH661924A5 (es)
CY (1) CY1541A (es)
DE (1) DE3435745C2 (es)
DK (1) DK169546B1 (es)
ES (1) ES536286A0 (es)
FI (1) FI83310C (es)
FR (1) FR2552759B1 (es)
GB (1) GB2147297B (es)
GR (1) GR80475B (es)
HK (1) HK37391A (es)
IE (1) IE58084B1 (es)
IT (1) IT1178522B (es)
LU (1) LU85561A1 (es)
MY (1) MY102123A (es)
NL (1) NL8402946A (es)
SE (1) SE465928B (es)
YU (1) YU45667B (es)
ZA (1) ZA847589B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
YU44721B (en) * 1983-11-30 1990-12-31 Bristol Myers Co Process for obtaining 4-(2-phenoxyethyl)-1,2,4-triazolone
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
US5504086A (en) * 1989-10-17 1996-04-02 Ellinwood, Jr.; Everett H. Intraoral dosing method of administering trifluorobenzodiazepines, propoxyphene, and nefazodone
US5256664A (en) * 1992-04-28 1993-10-26 Bristol-Myers Squibb Company Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones
DE4425144A1 (de) * 1994-07-15 1996-01-18 Basf Ag Triazolverbindungen und deren Verwendung
US6403593B1 (en) 1995-07-14 2002-06-11 Abbott Laboratories Triazole compounds and the use thereof
DE19728996A1 (de) 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
CA2369225A1 (en) 1999-04-09 2000-10-19 Sepracor Inc. S-hydroxynefazodone
ATE330607T1 (de) 1999-04-09 2006-07-15 Sepracor Inc R-hydroxynefazodon
US6469008B2 (en) 1999-04-09 2002-10-22 Sepracor Inc. (R)-hydroxynefazodone antipsychotic therapy
US6586437B2 (en) 1999-04-09 2003-07-01 Sepracor Inc. (S)-hydroxynefazodone antipsychotic therapy
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
WO2005102366A2 (en) * 2004-04-19 2005-11-03 Philip Maxwell Satow Lithium combinations, and uses related thereto
CA2789097C (en) 2005-04-28 2017-02-21 Proteus Digital Health, Inc. Pharma-informatics system
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
WO2009111031A2 (en) * 2008-03-04 2009-09-11 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
NZ596876A (en) 2009-05-06 2014-01-31 Lab Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
WO2013036830A1 (en) * 2011-09-09 2013-03-14 The Board Of Trustees Of The Leland Standford Junior University Topical itraconazole formulations and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
IT1052119B (it) * 1972-10-16 1981-06-20 Sigma Tau Ind Farmaceuti Derivati del triazolinone e procedimento per la loro preparazione
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants

Also Published As

Publication number Publication date
ZA847589B (en) 1985-05-29
YU45667B (sh) 1992-07-20
KR850002270A (ko) 1985-05-10
SE8404869D0 (sv) 1984-09-28
IE842476L (en) 1985-03-30
FR2552759A1 (fr) 1985-04-05
LU85561A1 (fr) 1985-06-04
ATA310884A (de) 1988-09-15
YU172184A (en) 1986-10-31
GB2147297B (en) 1987-04-15
IE58084B1 (en) 1993-06-30
MY102123A (en) 1992-03-31
GB2147297A (en) 1985-05-09
HK37391A (en) 1991-05-24
JPS60100560A (ja) 1985-06-04
CY1541A (en) 1991-03-22
KR880002624B1 (ko) 1988-12-07
FI83310B (fi) 1991-03-15
CH661924A5 (de) 1987-08-31
FR2552759B1 (fr) 1988-10-07
US4613600A (en) 1986-09-23
DE3435745C2 (de) 1994-11-03
GB8424535D0 (en) 1984-11-07
SE8404869L (sv) 1985-03-31
CA1237723A (en) 1988-06-07
AT387963B (de) 1989-04-10
FI843779A0 (fi) 1984-09-26
BE900714A (fr) 1985-03-28
DK169546B1 (da) 1994-11-28
DE3435745A1 (de) 1985-04-11
JPH0542435B2 (es) 1993-06-28
SE465928B (sv) 1991-11-18
DK468284D0 (da) 1984-09-28
FI83310C (fi) 1991-06-25
NL8402946A (nl) 1985-04-16
IT1178522B (it) 1987-09-09
DK468284A (da) 1985-03-31
ES8601966A1 (es) 1985-11-16
IT8422922A0 (it) 1984-09-28
GR80475B (en) 1985-01-31
AU561460B2 (en) 1987-05-07
FI843779L (fi) 1985-03-31
AU3364884A (en) 1985-04-04

Similar Documents

Publication Publication Date Title
ES538256A0 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
ES539625A0 (es) Un procedimiento para la preparacion de derivados de fenetano.
ES521121A0 (es) Un procedimiento para la preparacion de derivados de benzotia-zolsulfonamida.
ES533753A0 (es) Un procedimiento para la preparacion de nuevas fenoxialquil-1-2-4-triazolonas.
ES536286A0 (es) Un procedimiento para la preparacion de compuestos de 1,4,4-triazolona.
ES534892A0 (es) Un procedimiento para la preparacion de derivados de penem-2-metil sustituidos.
ES536525A0 (es) Un procedimiento para la preparacion de derivados de fenotiazinas.
ES535953A0 (es) Un procedimiento para la preparacion de derivados 3-cefem-4-carboxilicos.
ES530379A0 (es) Un procedimiento para la preparacion de compuestos de 1, 4-dihidropiridina.
ES530418A0 (es) Un procedimiento para la preparacion de pirazolopiridinas.
ES538907A0 (es) Un procedimiento para la preparacion de derivados enol-eteres de oxicanis.
ES521318A0 (es) Un procedimiento para la preparacion de compuestos de bencimidazol.
ES534607A0 (es) Un procedimiento para la preparacion de un derivado de poliol-eter.
ES529846A0 (es) Un procedimiento para la preparacion de derivados benzoheterociclicos.
ES531792A0 (es) Un procedimiento para la preparacion de un compuesto.
ES521192A0 (es) Un procedimiento para la preparacion de derivados de b-lactama.
ES533389A0 (es) Un procedimiento para la preparacion de nuevos derivados de tiosulfonamida.
ES529213A0 (es) Un procedimiento para la preparacion de derivados de isoquinuclidina.
ES534642A0 (es) Un procedimiento para la preparacion de nuevos derivados de carbaciclina.
ES528225A0 (es) Un procedimiento para la preparacion de nuevos derivados de 1,2,5,-tidiazol.
ES535551A0 (es) Un procedimiento para la preparacion de nuevos 16-fluor-16,17-dideshidro prostanoides.
ES531760A0 (es) Un metodo para la preparacion de 1,8-dihidroxi-10-acil-9-antronas.
ES534269A0 (es) Un procedimiento para la preparacion de nuevos derivados de difeniletanona.
ES535966A0 (es) Un procedimiento para la preparacion de nuevos derivados de 4,5-dihidro-2h-piridazin-3-ona.
ES528986A0 (es) Un procedimiento para la preparacion de un compuesto de beta-lactama.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050709